Prevalence of chronic obstructive pulmonary disease and variation in risk factors across four geographically diverse resource-limited settings in Peru

Respiratory Research

Volumn 16, Issue 1, 2015, Pages

  Jaganath, Devan ^a,b   Miranda, J Jaime ^c,d   Gilman, Robert H ^b   Wise, Robert A ^a   Diette, Gregory B ^a   Miele, Catherine H ^a   Bernabe Ortiz, Antonio ^c   Checkley, William ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c CRONICAS CENTER OF EXCELLENCE IN CHRONIC DISEASES   (Peru)

^d UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

Biomass fuels; Chronic disease; COPD; Peru; Population studies; Respiratory disease; Risk factors

Indexed keywords

FUEL; SALBUTAMOL; FOSSIL FUEL;

ADULT; AGE; AGED; ALTITUDE; ALTITUDE ACCLIMATIZATION; ARTICLE; ASTHMA; ATTRIBUTABLE RISK; BRONCHOSPIROGRAPHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COOKING; DISEASE ASSOCIATION; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GEOGRAPHIC DISTRIBUTION; HUMAN; LUNG FUNCTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; MULTICENTER STUDY; PERU; POPULATION RESEARCH; PREVALENCE; RISK FACTOR; RURAL AREA; SMOKING; SOCIAL STATUS; SPIROMETER; TREATMENT RESPONSE; URBAN AREA; URBANIZATION; ADVERSE EFFECTS; BIOMASS; COMPARATIVE STUDY; DEMOGRAPHY; HEALTH; LONGITUDINAL STUDY; LUNG; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; SPIROMETRY; TUBERCULOSIS, PULMONARY; VITAL CAPACITY;

ADULT; AGED; ALTITUDE; BIOMASS; FEMALE; FORCED EXPIRATORY VOLUME; FOSSIL FUELS; HUMANS; LONGITUDINAL STUDIES; LUNG; MALE; MIDDLE AGED; PERU; PREDICTIVE VALUE OF TESTS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESIDENCE CHARACTERISTICS; RISK ASSESSMENT; RISK FACTORS; RURAL HEALTH; SMOKING; SPIROMETRY; TUBERCULOSIS, PULMONARY; URBAN HEALTH; URBANIZATION; VITAL CAPACITY;

EID: 84926344101     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/s12931-015-0198-2     Document Type: Article

References (30)

1. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2197-223.
2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2095-128.
3. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (The BOLD study): a population-based prevalence study. Lancet. 2007;370:741-50.
4. Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, et al. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182:693-718.
5. Hooper R, Burney P, Vollmer WM, McBurnie MA, Gislason T, Tan WC, et al. Risk factors for COPD spirometrically defined from the lower limit of normal in the BOLD project. Eur Respir J. 2012;39:1343-53.
6. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765-73.
7. Bousquet J, Kiley J, Bateman ED, Viegi G, Cruz AA, Khaltaev N, et al. Prioritised research agenda for prevention and control of chronic respiratory diseases. Eur Respir J. 2010;36:995-1001.
8. Checkley W, Ghannem H, Irazola V, Kimaiyo S, Levitt NS, Miranda JJ, et al. Management of NCD in low- and middle-income countries. Glob Heart. 2014;9:431-43.
9. Aït-Khaled N, Enarson DA, Ottmani S, El Sony A, Eltigani M, Sepulveda R. Chronic airflow limitation in developing countries: burden and priorities. Int J Chron Obstruct Pulmon Dis. 2007;2:141-50.
10. Duong M, Islam S, Rangarajan S, Teo K, O'Byrne PM, Schünemann HJ, et al. Global differences in lung function by region (PURE): an international, community-based prospective study. Lancet Respir Med. 2013;1:599-609.
11. Menezes AM, Perez-Padilla R, Jardim JR, Muiño A, Lopez MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366:1875-81.
12. Menezes AM, Jardim JR, Pérez-Padilla R, Camelier A, Rosa F, Nascimento O, et al. Prevalence of chronic obstructive pulmonary disease and associated factors: the PLATINO study in Sao Paulo, Brazil. Cad Saude Publica. 2005;21:1565-73.
13. Caballero A, Torres-Duque CA, Jaramillo C, Bolívar F, Sanabria F, Osorio P, et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest. 2008;133:343-9.
14. Miranda JJ, Bernabe-Ortiz A, Smeeth L, Gilman RH, Checkley W, CRONICAS Cohort Study Group. Addressing geographical variation in the progression of non-communicable diseases in Peru: the CRONICAS cohort study protocol. BMJ Open. 2012;2(1):e000610.
15. Instituto Nacional de Estadística e Informática and ICF International. Peru DHS, 2012. Lima, Peru; 2013.
16. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319-38.
17. Ferguson GT, Enright PL, Buist AS, Higgins MW. Office spirometry for lung health assessment in adults: a consensus statement from the national lung health education program. Chest. 2000;117:1146-61.
18. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;163:1256-76.
19. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159:179-87.
20. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40:1324-43.
21. Howe LD, Galobardes B, Matijasevich A, Gordon D, Johnston D, Onwujekwe O, et al. Measuring socio-economic position for epidemiological studies in low-and middle-income countries: a methods of measurement in epidemiology paper. Int J Epidemiol. 2012;41:871-86.
22. Barros AS, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3:21.
23. Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics. 2000;56:645-6.
24. Menezes AM, Lopez MV, Hallal PC, Muiño A, Perez-Padilla R, Jardim JR, et al. Prevalence of smoking and incidence of initiation in the Latin American adult population: the PLATINO study. BMC Public Health. 2009;9:151.
25. Havryk AP, Gilbert M, Burgess KR. Spirometry values in Himalayan high altitude residents (Sherpas). Respir Physiol Neurobiol. 2002;132:223-32.
26. Rupert JL, Hochachka PW. The evidence for hereditary factors contributing to high altitude adaptation in Andean natives: a review. High Alt Med Biol. 2001;2:235-56.
27. Torres-Duque C, Maldonado D, Pérez-Padilla R, Ezzati M, Viegi G, Forum of International Respiratory Studies (FIRS) Task Force on Health Effects of Biomass Exposure. Biomass fuels and respiratory diseases. Proc Am Thorac Soc. 2008;5:577-90.
28. Kurmi OP, Semple S, Simkhada P, Smith WC, Ayres J. COPD and chronic bronchitis risk of indoor air pollution from solid fuel: a systematic review and meta-analysis. Thorax. 2010;65:221-8.
29. Menezes AM, Hallal PC, Perez-Padilla R, Jardim JR, Muiño A, Lopez MV, et al. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America. Eur Respir J. 2007;30:1180-5.
30. Po JY, FitzGerald JM, Carlsten C. Respiratory disease associated with solid biomass fuel exposure in rural women and children: systematic review and meta-analysis. Thorax. 2011;66:232-9.